Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma von KIRSCHBAUM, Mark, FRANKEL, Paul, NADEMANEE, Auayporn, FORMAN, Stephen J, GANDARA, David, NEWMAN, Edward, POPPLEWELL, Leslie, ZAIN, Jasmine, DELIOUKINA, Maria, PULLARKAT, Vinod, MATSUOKA, Deron, PULONE, Bernadette, ROTTER, Arnold J, ESPINOZA-DELGADO, Igor

Volltext

A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia von Kirschbaum, M H, Synold, T, Stein, A S, Tuscano, J, Zain, J M, Popplewell, L, Karanes, C, O'Donnell, M R, Pulone, B, Rincon, A, Wright, J, Frankel, P, Forman, S J, Newman, E M

Volltext

Brentuximab Vedotin (SGN-35) Enables Successful Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma von Chen, Robert W., Forman, Stephen J., Palmer, Joycelynne, Tsai, Ni-Chun, Popplewell, Leslie, Delioukina, Maria L, Alejandra, Torres, Pulone, Bernadette, Smith, Eileen P., Nademanee, Auayporn P., Karanes, Chatchada, O'Donnell, Paul, Maloney, David G., Farol, Len, Tsai, Schickwann, Grove, Laurie E., Gopal, Ajay K.

Volltext

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma. A California Cancer Consortium Study von Kirschbaum, Mark, Popplewell, Leslie, Nademanee, Auayporn P., Pullarkat, Vinod, Delioukina, Maria, Zain, Jasmine M., Matsuoka, Deron, Pulone, Bernadette, Frankel, Paul, Espinoza-Delgado, Igor, Forman, Stephen J., Gandara, David, Newman, Edward

Volltext

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non Hodgkin Lymphoma. A California Cancer Consortium Study von Kirschbaum, Mark H., Zain, Jasmine M., Popplewell, Leslie, Pullarkat, Vinod, Nademanee, Auayporn P., Delioukina, Maria L., Pulone, Bernadette, Matsuoka, Deron, Frankel, Paul, James, Zwiebel A., Forman, Stephen J., Newman, Edward, Gandara, David

Volltext

A Phase I Study of the Farnesyltransferase Inhibitor Tipifarnib in a Week-On Week-Off Dose Schedule in Acute Myelogenous Leukemia von Kirschbaum, Mark H., Stein, Anthony Selwyn, Tuscano, Joseph, Zain, Jasmine M., Popplewell, Leslie, O'Donnell, Margaret R., Karanes, Chatchada, Wright, John, Pulone, Bernadette, Rincon, Amalia, Frankel, Paul, Forman, Stephen J., Newman, Edward

Volltext

A Phase I Study of the Farnesyltransferase Inhibitor Tipifarnib in a Week- on Week-Off Dose Schedule in Acute Myelogenous Leukemia von Kirschbaum, Mark, Selwyn Stein, Anthony, Tuscano, Joseph, Zain, Jasmine M., Popplewell, Leslie, O'Donnell, Margaret R., Karanes, Chatchada, Krishnan, Amrita, Wright, John J., Pulone, Bernadette, Rincon, Amalia, Frankel, Paul, Forman, Stephen J., Edward, Newman

Volltext

Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN) von Hawkins, Donna, Irenze, Kathryn, Krupka, Emily, Logan, Kiausha, Patané, Kathryn, Pulone, Bernadette, Gorospe, Gerardo, Jones, Naomi

Volltext